Error: Could not add to watchlist. X

Amicus Therapeutics Inc

+ Watchlist
FOLD:US
NASDAQ GM
13.77
USD
0.25
1.78%
As of 14:20:28 ET on 07/02/2015.
Open
14.04
Day Range
13.42 - 14.05
Volume
1,367,115
Previous Close
14.02
52Wk Range
3.50 - 14.65
1 Yr Return
248.49%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.94
Market Cap (b USD)
1.568
Shares Outstanding (m)
113.356
Price/Sales (TTM)
1,286.97
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
ADDRESS
6 Cedar Brook Drive
Cranbury, NJ 08512
United States
PHONE
1-609-662-2000
  • John F Crowley
    Chairman/CEO
  • Bradley L Campbell
    President/COO
  • William D Baird "Chip"
    Chief Financial Officer
  • Jay Barth
    Chief Medical Ofcr
  • Hung Do
    Chief Science Officer
Show More